Modern Chinese Medicine Group (HKG:1643) expects an attributable profit of at least 2 million yuan in the first half of 2025, compared with a loss of 6.9 million yuan a year prior, an Aug. 15 Hong Kong bourse filing said.
Shares of the Chinese medicine manufacturer were down 6% in Monday afternoon trading.
The firm attributed the forecast to a significant drop in disposal loss on property, plant, and equipment.